Free Trial

Bio-Rad Laboratories (BIO) News Today

$281.40
-3.05 (-1.07%)
(As of 03:55 PM ET)
Caxton Associates LP Has $3.45 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Caxton Associates LP boosted its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 472.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,677 shares of the medical research
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by Bellevue Group AG
Bellevue Group AG increased its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 5.1% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 141,147 shares of the medical research company's stock after acquiring an additi
The Manufacturers Life Insurance Company Purchases 55,369 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
The Manufacturers Life Insurance Company raised its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 303.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,610 shares of t
Quadrature Capital Ltd Boosts Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Quadrature Capital Ltd increased its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 87.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 23,820 shares of the medical research company's stock
CIBC Private Wealth Group LLC Takes $13.98 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)
CIBC Private Wealth Group LLC bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 43,287 shares of the medical research
Eisler Capital UK Ltd. Purchases Shares of 3,132 Bio-Rad Laboratories, Inc. (NYSE:BIO)
Eisler Capital UK Ltd. acquired a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 3,132 shares of the medical research company's st
Bio-Rad Laboratories, Inc. (NYSE:BIO) Short Interest Update
Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 653,400 shares, a drop of 10.9% from the April 30th total of 733,100 shares. Based on an average daily volume of 202,100 shares, the days-to-cover ratio is presently 3.2 days. Approximately 3.3% of the company's shares are short sold.
Campbell & CO Investment Adviser LLC Buys Shares of 8,080 Bio-Rad Laboratories, Inc. (NYSE:BIO)
Campbell & CO Investment Adviser LLC purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 8,080 shares of the medical research company's s
Jefferies Financial Group Reaffirms "Hold" Rating for Bio-Rad Laboratories (NYSE:BIO)
Jefferies Financial Group reaffirmed a "hold" rating and set a $315.00 price target (down previously from $440.00) on shares of Bio-Rad Laboratories in a research note on Monday.
UBS Group AG Sells 4,431 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
UBS Group AG decreased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 11.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 35,496 shares of the medical research company's stock afte
Franklin Resources Inc. Cuts Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Franklin Resources Inc. cut its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 27.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 19,000 shares of the medical research company's stock after selling 7,3
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Purchased by Parnassus Investments LLC
Parnassus Investments LLC boosted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 7.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 237,790 shares of the medical research company's stock after a
Bio-Rad Laboratories, Inc. (NYSE:BIO) Expected to Post Q2 2025 Earnings of $2.64 Per Share
Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Equities research analysts at Zacks Research boosted their Q2 2025 EPS estimates for Bio-Rad Laboratories in a note issued to investors on Tuesday, May 28th. Zacks Research analyst R. Anand now expects that the medical research company will po
First Pacific Advisors LP Acquires New Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)
First Pacific Advisors LP acquired a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 4,866 shares of the medical research company's stock, valued at approximately
Bio-Rad Laboratories Q1 Earnings Transcript
Bio-Rad Laboratories (NYSE:BIO) Upgraded to "Buy" at StockNews.com
StockNews.com upgraded Bio-Rad Laboratories from a "hold" rating to a "buy" rating in a research report on Tuesday.
226,523 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Acquired by Norges Bank
Norges Bank purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 226,523 shares of the medical research company's stock, va
Westfield Capital Management Co. LP Sells 115,118 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Westfield Capital Management Co. LP lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 31.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 247,210 shares of the medical research company
Brown Advisory Inc. Cuts Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Brown Advisory Inc. lessened its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 98.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,569 shares of the medical research
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Moderate Buy" from Brokerages
Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the five research firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and four have assigned a buy recom
ING Groep NV Boosts Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)
ING Groep NV increased its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 5,200.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 6,466 shares of the medical research company's stock after purchasing an additional 6,344 shares
GW&K Investment Management LLC Sells 6,921 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
GW&K Investment Management LLC reduced its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 137,793 shares of the medical research company's sto
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Envestnet Portfolio Solutions Inc.
Envestnet Portfolio Solutions Inc. cut its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 50.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,551 shares of the medical research company's stoc
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by BNP Paribas Financial Markets
BNP Paribas Financial Markets boosted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 88.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 26,925 shares of the medical research c
Jump Financial LLC Purchases Shares of 5,163 Bio-Rad Laboratories, Inc. (NYSE:BIO)
Jump Financial LLC purchased a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,163 shares of the medical rese
Precision BioSciences earnings: here's what Wall Street expects
Roubaix Capital LLC Makes New $4.05 Million Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Roubaix Capital LLC purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 12,549 shares of the medical research com
Mawer Investment Management Ltd. Cuts Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Mawer Investment Management Ltd. reduced its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 23.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 123,878 shares of the medical researc
Natixis Advisors L.P. Boosts Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Natixis Advisors L.P. raised its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 17.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,744 shares of the
Swiss National Bank Sells 3,400 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Swiss National Bank lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 67,600 shares of the medical research company's stock after selling 3,400 shares during the peri
Bio-Rad Laboratories (NYSE:BIO) Releases Quarterly Earnings Results, Beats Expectations By $0.25 EPS
Bio-Rad Laboratories (NYSE:BIO - Get Free Report) released its earnings results on Tuesday. The medical research company reported $2.29 EPS for the quarter, beating the consensus estimate of $2.04 by $0.25. The firm had revenue of $610.82 million during the quarter, compared to analysts' expectations of $619.09 million. Bio-Rad Laboratories had a negative net margin of 23.86% and a positive return on equity of 3.90%. The business's quarterly revenue was down 9.8% compared to the same quarter last year. During the same period in the prior year, the company earned $3.34 EPS.
Bio-Rad Laboratories (NYSE:BIO) Price Target Cut to $385.00 by Analysts at UBS Group
UBS Group decreased their price objective on Bio-Rad Laboratories from $420.00 to $385.00 and set a "buy" rating for the company in a report on Wednesday.
Q1 2024 Bio Rad Laboratories Inc Earnings Call
Truist Financial Corp Cuts Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Truist Financial Corp trimmed its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 21.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,635 shares of the medical research company's stock aft
Fisher Asset Management LLC Sells 14,338 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Fisher Asset Management LLC lowered its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 15.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 80,570 shares of the medical research company's stock after selling 14,33
Bio-Rad Laboratories (BIO) Scheduled to Post Earnings on Tuesday
Bio-Rad Laboratories (NYSE:BIO) will be releasing earnings after the market closes on Tuesday, May 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=586339)
Anchor Capital Advisors LLC Sells 20,844 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Anchor Capital Advisors LLC lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 21.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 76,698 shares of the m
IFM Investors Pty Ltd Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)
IFM Investors Pty Ltd bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 4,057 shares of the medical research company's stock, valued at approx
Sector Gamma AS Makes New $7.62 Million Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Sector Gamma AS bought a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 23,609 shares of the medical research company's stock, valued at approximately

BIO Media Mentions By Week

BIO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BIO
News Sentiment

1.29

0.74

Average
Medical
News Sentiment

BIO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BIO Articles
This Week

7

5

BIO Articles
Average Week

Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:BIO) was last updated on 6/11/2024 by MarketBeat.com Staff

From Our Partners